[Press Release] Effectiveness of XAV19 against SARS-CoV-2 variants

[Press Release] XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody.

December 16,2022. # Download our press release (english version) # Télécharger notre...

More

[Press Release] XENOTHERA signs a memorandum of understanding with the Vietnamese conglomerate Vingroup

September 9,2021. # Download our press release (english version) # Télécharger notre...

More

[Press Release] 20 M€ raised by XENOTHERA to accelerate its development

June 29, 2021. # Download our press release (english version) # Télécharger...

More